They concluded that circulating exosomal miR-96 played a promotive role in lung cancer cell proliferation and migration by targeting LIM-domain-only protein 7 (LMO7) and that treatment with a miR-96 inhibitor or the overexpression of LMO7 could reverse this promotive action. The gene discussed is LMO7; the disease is lung cancer.